Skip to content

Clinical trials

Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20111
20121
20131
20151
20162
20181
20192
20201
20213
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Active, not recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
ADC Therapeutics S.A.1
Bambino Gesù Hospital and Research Institute1
BeOne Medicines1
Bristol-Myers Squibb1
Celgene1
Epizyme, Inc.1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse19
Lymphoma, Follicular9
Lymphoma, Non-Hodgkin8
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Mantle-Cell7
Burkitt Lymphoma5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Hodgkin Disease4
Lymphoma3
Lymphoma, B-Cell3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.